Humacyte, Inc.

Humacyte, Inc.verified

HUMA

Price:

$1.055

Market Cap:

$177.24M

Humacyte, Inc. focuses on developing and manufacturing readily available, implantable human tissues engineered in a laboratory setting. These bioengineered tissues are designed to treat a wide array of diseases and conditions across various anatomical locations and therapeutic fields. The company employs its distinct scientific and proprietary technology platform to produce human acellular vessels (HAVs). These investigational HAVs are specifically crafted for universal compatibility, enabling easy implantation into any patient without inducing an immune rejection or an adverse foreign body response. Humacyte is currently building a pipeline of HAVs targeting the substantial market for vascu...[Read more]

Industry

Biotechnology

IPO Date

2020-12-01

Stock Exchange

NASDAQ

Ticker

HUMA

The Enterprise Value as of June 2026 (TTM) for Humacyte, Inc. (HUMA) is 194.60M

According to Humacyte, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 194.60M. This represents a change of -18.94% compared to the average of 240.06M of the last 4 quarters.

Humacyte, Inc. (HUMA) Historical Enterprise Value (quarterly & annually)

How has HUMA Enterprise Value performed in the past?

The mean historical Enterprise Value of Humacyte, Inc. over the last ten years is 213.31M. The current 194.60M Enterprise Value has changed 9.02% with respect to the historical average. Over the past ten years (40 quarters), HUMA's Enterprise Value was at its highest in in the March 2021 quarter at 1.12B. The Enterprise Value was at its lowest in in the December 2019 quarter at -64995000.00.

Quarterly (TTM)
Annual

Average

213.31M

Median

129.57M

Minimum

115.54M

Maximum

569.92M

Humacyte, Inc. (HUMA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Humacyte, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 129.94%

Maximum Annual Enterprise Value = 569.92M

Minimum Annual Increase = -70.83%

Minimum Annual Enterprise Value = 115.54M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025166.26M-70.83%
2024569.92M110.52%
2023270.72M129.94%
2022117.73M-4.64%
2021123.46M6.86%
2020115.54M-10.83%

Humacyte, Inc. (HUMA) Average Enterprise Value

How has HUMA Enterprise Value performed in the past?

The current Enterprise Value of Humacyte, Inc. (HUMA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

335.63M

5-year avg

249.62M

10-year avg

213.31M

Humacyte, Inc. (HUMA) Enterprise Value vs. Peers

How is HUMA’s Enterprise Value compared to its peers?

Humacyte, Inc.’s Enterprise Value is less than Entrada Therapeutics, Inc. (224.09M), greater than Arcturus Therapeutics Holdings Inc. (6.41M), less than Achieve Life Sciences, Inc. (553.55M), less than Voyager Therapeutics, Inc. (202.73M), greater than Sagimet Biosciences Inc. (174.54M), greater than Immuneering Corporation (-43439255204.00), less than Vanda Pharmaceuticals Inc. (312.03M), less than Foghorn Therapeutics Inc. (198.51M), less than Atea Pharmaceuticals, Inc. (280.64M), less than Nautilus Biotechnology, Inc. (298.90M),

Build a custom stock screener for Humacyte, Inc. (HUMA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Humacyte, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Humacyte, Inc. (HUMA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Humacyte, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Humacyte, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Humacyte, Inc. (HUMA)?

What is the 3-year average Enterprise Value for Humacyte, Inc. (HUMA)?

What is the 5-year average Enterprise Value for Humacyte, Inc. (HUMA)?

How does the current Enterprise Value for Humacyte, Inc. (HUMA) compare to its historical average?